Allergen (AGN) PT Raised to $242 at Leerink Partners
Tweet Send to a Friend
Leerink Partners raised its price target on Allergen (NYSE: AGN) to $242.00 (from $237.00) while maintaining a Outperform rating.Analyst Seamus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
